Rimonabant, a cannabinoid receptor 1 antagonist, protects LDL receptor deficient mice from atherosclerosis.

被引：0
|
作者：
Dol-Gleizes, Frederique [1 ]
Visentin, Virgile [1 ]
Mares, Anne-Marie [1 ]
Schaeffer, Paul [1 ]
Bono, Francoise [1 ]
机构：
[1] Sanofi Aventis, Toulouse, France
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [1] Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor-Deficient Mice
    Dol-Gleizes, Frederique
    Paumelle, Rejane
    Visentin, Virgile
    Mares, Anne-Marie
    Desitter, Perrine
    Hennuyer, Nathalie
    Gilde, Andries
    Staels, Bart
    Schaeffer, Paul
    Bono, Francoise
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (01) : 12 - U40
  • [2] APOPROTEIN A5 PROTECTS FROM ATHEROSCLEROSIS IN APOE AND IN LDL RECEPTOR DEFICIENT MICE
    Merkel, M.
    Naumann, A.
    Bruns, O.
    Laatsch, A.
    Teupser, D.
    Gords, P.
    Heeren, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [3] Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist Rimonabant
    Bergstrom, Moa Andresen
    Isin, Emre M.
    Castagnoli, Neal, Jr.
    Milne, Claire E.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (10) : 1823 - 1832
  • [4] Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
    Delsing, Dianne J. M.
    Leijten, Frank P.
    Arts, Karin
    van Eenennaam, Hans
    Garritsen, Anja
    Gijbels, Marion J. J.
    de Winther, Menno P. J.
    van Elsas, Andrea
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2011, 5 : 15 - 21
  • [5] The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction
    Lim, Shiang Y.
    Davidson, Sean M.
    Yellon, Derek M.
    Smith, Christopher C. T.
    BASIC RESEARCH IN CARDIOLOGY, 2009, 104 (06) : 781 - 792
  • [6] The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction
    Shiang Y. Lim
    Sean M. Davidson
    Derek M. Yellon
    Christopher C. T. Smith
    Basic Research in Cardiology, 2009, 104 : 781 - 792
  • [7] LDL-receptor-deficient mice with impaired Natural Killer cells (Lystbeige) have increased atherosclerosis.
    Schiller, NK
    Boisvert, WA
    Curtiss, LK
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 660 - 660
  • [8] Inhibition of atherosclerosis in LDL receptor deficient mice by endothelin receptor blockade
    Picard, P
    Babaei, S
    Smith, PJW
    Monge, JC
    Stewart, DJ
    CIRCULATION, 1998, 98 (17) : 310 - 310
  • [9] Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice
    Liu, Ting Ting
    Zeng, Yi
    Tang, Kun
    Chen, XueMeng
    Zhang, Wei
    Xu, Xiao Le
    ATHEROSCLEROSIS, 2017, 262 : 39 - 50
  • [10] Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats
    Molhoj, Signe
    Hansen, Harald S.
    Schweiger, Martina
    Zimmermann, Robert
    Johansen, Thue
    Malmlof, Kjell
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 646 (1-3) : 38 - 45
12345